Agios Pharmaceuticals, Inc.(NASDAQ : AGIO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||0.31%||209.08||1.9%||$520.46m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.72%||449.95||2.7%||$506.82m|
|GILD||Gilead Sciences, Inc.||1.60%||63.76||1.0%||$487.79m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.05%||148.12||2.0%||$341.36m|
|CRSP||CRISPR Therapeutics AG||-3.43%||115.00||0.6%||$273.24m|
|BNGO||Bionano Genomics, Inc.||-19.33%||6.90||0.0%||$244.02m|
|EXAS||EXACT Sciences Corp.||-3.71%||121.88||18.4%||$227.29m|
|PACB||Pacific Biosciences of California, Inc.||-6.28%||29.02||7.2%||$153.53m|
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.